ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,20/161,100/3279,0.2,4.073291925465839,7.091496749648929,3.704311995269042e-8,1.600262781956226e-5,1.2711639057449556e-5,GADD45B/VEGFA/TENT5A/HES1/SPP1/NR4A3/EGR1/EGR2/NR4A1/CDKN1A/IL1B/IL6/MYC/HCRTR2/PDK1/RUNX1/NOS3/NPAS4/MAFF/ARC,20
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,16/161,71/3279,0.22535211267605634,4.589624704750241,6.9476894379601015,1.6598371796419086e-7,3.5852483080265224e-5,2.847931160859275e-5,XYLT1/CCL2/IL1R1/GADD45A/EGR1/NR4A1/CDK2/IL1B/PLA2G5/ZFP36/IL6/MYC/FCGR2A/GDNF/BDNF/COL4A1,16
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,13/161,49/3279,0.2653061224489796,5.403346431740398,7.056006802668877,3.3497906993687615e-7,4.8236986070910164e-5,3.831690414014795e-5,PLAUR/SELPLG/CR2/SPP1/CD93/F12/TLR2/THBS1/ADM/ALB/FPR1/FCGR3A/ITGB3,13
WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,11/161,47/3279,0.23404255319148937,4.766618210651513,5.909411213019464,1.0642805726704463e-5,0.001149423018484082,9.130407018172776e-4,CCL2/VEGFA/EGR1/NR4A1/IL1B/IL6/HK2/MST1R/CLDN5/SOCS3/COL4A1,11
WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,6/161,13/3279,0.46153846153846156,9.399904443382704,6.894730397341954,1.6456882090875287e-5,0.0013328503229542595,0.0010587456269081108,TNFRSF12A/TNFRSF1A/IL1R1/IL1B/IL6/PDK1,6
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,9/161,33/3279,0.2727272727272727,5.554488989271598,5.9745022068255995,1.8511810041031382e-5,0.0013328503229542595,0.0010587456269081108,BBC3/CCL2/GADD45A/TNFRSF10B/CDK2/CDKN1A/LIF/THBS1/TNFRSF10D,9
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,13/161,77/3279,0.16883116883116883,3.4384931838347987,4.919665805172094,7.024782932445764e-5,0.004107193805950349,0.003262536990106759,SERPINB1/IL1RL1/GADD45A/SPP1/CDK2/CDKN1A/STEAP4/HILPDA/MYC/S100A9/IL12A/CD14/THBD,13
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,7/161,23/3279,0.30434782608695654,6.198487712665407,5.684314506160545,7.60591445546361e-5,0.004107193805950349,0.003262536990106759,GADD45B/BBC3/GADD45A/TNFRSF10B/CDK2/CDKN1A/MYC,7
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,7/161,26/3279,0.2692307692307692,5.483277591973244,5.214583541211728,1.8007228085474328e-4,0.008643469481027677,0.00686591386650834,GADD45B/BBC3/GADD45A/TNFRSF10B/CDK2/CDKN1A/MYC,7
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,6/161,19/3279,0.3157894736842105,6.431513566525008,5.394711524469763,2.0324280794323056e-4,0.00878008930314756,0.006974437409420334,CD44/VEGFA/CDKN1A/IL6/MYC/CXCR1,6
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,12/161,77/3279,0.15584415584415584,3.1739937081551988,4.38603748313573,2.959017981195099e-4,0.010735803738463709,0.008527953262035013,SLC38A5/TNFRSF1A/IL4R/IL1R1/IL1B/LIF/IL6/FGF2/IL12A/BDNF/SOCS3/ARC,12
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,7/161,28/3279,0.25,5.091614906832298,4.940201239653211,2.982167705128808e-4,0.010735803738463709,0.008527953262035013,EDN1/CCL2/SPP1/MT2A/IL1B/IL6/FGF2,7
WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,5/161,14/3279,0.35714285714285715,7.273735581188998,5.344757345280522,3.7430823459337647e-4,0.011315078754430274,0.008988098620721904,CCL2/IL1R1/IL1B/TLR2/S100A9,5
WP_ZINC_HOMEOSTASIS,WP_ZINC_HOMEOSTASIS,5/161,14/3279,0.35714285714285715,7.273735581188998,5.344757345280522,3.7430823459337647e-4,0.011315078754430274,0.008988098620721904,MT2A/MT1X/MT1A/MT1M/MT1L,5
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,8/161,38/3279,0.21052631578947367,4.2876757110166714,4.631488746438087,3.928846789732734e-4,0.011315078754430274,0.008988098620721904,OSM/CCL2/VEGFA/SPP1/IL1B/LIF/IL6/IL12A,8
WP_ONCOSTATIN_M_SIGNALING,WP_ONCOSTATIN_M_SIGNALING,7/161,31/3279,0.22580645161290322,4.598877980364656,4.5742438834807215,5.845828007722705e-4,0.015783735620851305,0.012537762700773697,OSM/CCL2/VEGFA/EGR1/CDK2/OSMR/SOCS3,7
WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,5/161,16/3279,0.3125,6.3645186335403725,4.887216403348921,7.536794201280036e-4,0.018088306083072086,0.01436839128431165,CCL2/VEGFA/IL1B/IL6/IL12A,5
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,5/161,16/3279,0.3125,6.3645186335403725,4.887216403348921,7.536794201280036e-4,0.018088306083072086,0.01436839128431165,TNFRSF1A/VEGFA/IL1B/IL6/BCL2A1,5
WP_PROSTAGLANDIN_SIGNALING,WP_PROSTAGLANDIN_SIGNALING,5/161,17/3279,0.29411764705882354,5.990135184508587,4.6867754948555165,0.0010257736027203504,0.023322852440799544,0.018526437367691648,CCL2/VEGFA/IL1B/IL6/IL12A,5
WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,3/161,5/3279,0.6,12.219875776397515,5.704440707412361,0.0010803188511539514,0.02333488718492535,0.018535997130325693,CHI3L1/MYC/SOCS3,3
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,8/161,45/3279,0.17777777777777778,3.6207039337474125,4.021921288179255,0.0012908782388727507,0.0265552094853823,0.021094050419675024,TNFRSF1A/BBC3/IL1R1/TNFRSF10B/BCL2A1/BAG3/TNFRSF10D/CASP4,8
WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,4/161,11/3279,0.36363636363636365,7.405985319028798,4.835268718734254,0.0014092284837696192,0.027672122954021612,0.02198126725879885,CCL2/IL1B/IL6/IL12A,4
WP_ADIPOGENESIS,WP_ADIPOGENESIS,9/161,58/3279,0.15517241379310345,3.160312700792461,3.771504328684237,0.001772233830175608,0.030293658167930528,0.024063675835149494,GADD45B/OSM/GADD45A/EGR2/CDKN1A/LIF/IL6/SOCS3/CEBPD,9
WP_BLADDER_CANCER,WP_BLADDER_CANCER,5/161,19/3279,0.2631578947368421,5.35959463877084,4.33005554561112,0.0017793334560634961,0.030293658167930528,0.024063675835149494,TYMP/VEGFA/CDKN1A/MYC/THBS1,5
WP_PI3KAKT_SIGNALING,WP_PI3KAKT_SIGNALING,17/161,161/3279,0.10559006211180125,2.1504957370471818,3.401255472905564,0.0019298881873637589,0.030293658167930528,0.024063675835149494,IL4R/OSM/VEGFA/SPP1/CDK2/CDKN1A/IL6/MYC/TLR2/THBS1/FGF2/OSMR/NOS3/EFNA1/BDNF/COL4A1/ITGB3,17
WP_ACUTE_MYELOID_LEUKEMIA,WP_ACUTE_MYELOID_LEUKEMIA,6/161,28/3279,0.21428571428571427,4.364241348713398,4.061973000844706,0.0019522228463402737,0.030293658167930528,0.024063675835149494,MYC/PIM1/BCL2A1/FCGR1A/RUNX1/CD14,6
WP_FOLATE_METABOLISM,WP_FOLATE_METABOLISM,6/161,28/3279,0.21428571428571427,4.364241348713398,4.061973000844706,0.0019522228463402737,0.030293658167930528,0.024063675835149494,MTHFD2/CCL2/IL1B/IL6/ALB/SERPINA3,6
WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,4/161,12/3279,0.3333333333333333,6.788819875776397,4.564418419908268,0.002033602052939781,0.030293658167930528,0.024063675835149494,IL1B/IL6/TLR2/CD14,4
WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,4/161,12/3279,0.3333333333333333,6.788819875776397,4.564418419908268,0.002033602052939781,0.030293658167930528,0.024063675835149494,CCL2/SELPLG/IL1B/TLR2,4
WP_TP53_NETWORK,WP_TP53_NETWORK,4/161,13/3279,0.3076923076923077,6.266602962255137,4.322883406512733,0.002826093349794874,0.03881122699018901,0.030829580893766126,BBC3/GADD45A/CDKN1A/MYC,4
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,5/161,21/3279,0.23809523809523808,4.849157054125998,4.020491018039955,0.0028749057029769636,0.03881122699018901,0.030829580893766126,MT2A/STEAP4/MT1X/MT1A/MT1L,5
WP_TH17_CELL_DIFFERENTIATION_PATHWAY,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,5/161,21/3279,0.23809523809523808,4.849157054125998,4.020491018039955,0.0028749057029769636,0.03881122699018901,0.030829580893766126,IL4R/IL1B/IL6/RUNX1/SOCS3,5
WP_PLEURAL_MESOTHELIOMA,WP_PLEURAL_MESOTHELIOMA,19/161,199/3279,0.09547738693467336,1.9445363463279126,3.1235553897189137,0.003413310132549823,0.0441272270888044,0.03505232951011266,TEAD3/CD44/BBC3/CCL2/VEGFA/CDK2/CDKN1A/IL1B/IL6/MYC/FGF2/PDK1/EFNA1/FOSL1/BDNF/CDH5/COL4A1/TEAD4/ITGB3,19
WP_COVID19_ADVERSE_OUTCOME_PATHWAY,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,3/161,7/3279,0.42857142857142855,8.728482697426797,4.650674760274737,0.003514023614044274,0.0441272270888044,0.03505232951011266,CCL2/IL1B/IL6,3
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,5/161,22/3279,0.22727272727272727,4.628740824392999,3.8800539925485302,0.003575122565065171,0.0441272270888044,0.03505232951011266,CCL2/IL1B/IL6/ALB/SERPINA3,5
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,4/161,14/3279,0.2857142857142857,5.818988464951198,4.105420711720319,0.003806807395875478,0.04444704851400558,0.035306378692899175,BBC3/CDK2/CDKN1A/MYC,4
WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,4/161,14/3279,0.2857142857142857,5.818988464951198,4.105420711720319,0.003806807395875478,0.04444704851400558,0.035306378692899175,CCL2/IL1B/IL6/CD14,4
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,5/161,23/3279,0.21739130434782608,4.427491223332433,3.7478088162176433,0.0043899520735662,0.04990682357317364,0.039643334514752944,VEGFA/CDK2/CDKN1A/CD36/MYC,5
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,6/161,33/3279,0.18181818181818182,3.702992659514399,3.545740399711647,0.004682191872115143,0.05186427919881389,0.041198233476640665,GADD45B/BBC3/GADD45A/CDKN1A/RAC2/MYC,6
WP_ANGIOGENESIS,WP_ANGIOGENESIS,3/161,8/3279,0.375,7.637422360248447,4.270547263438879,0.00542092976234291,0.052040925718491934,0.041338552105819625,VEGFA/FGF2/NOS3,3
WP_ASPIRIN_AND_MIRNAS,WP_ASPIRIN_AND_MIRNAS,3/161,8/3279,0.375,7.637422360248447,4.270547263438879,0.00542092976234291,0.052040925718491934,0.041338552105819625,VEGFA/PDK1/NOS3,3
WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,3/161,8/3279,0.375,7.637422360248447,4.270547263438879,0.00542092976234291,0.052040925718491934,0.041338552105819625,CCL2/MYC/FCGR3A,3
WP_MACROPHAGE_MARKERS,WP_MACROPHAGE_MARKERS,3/161,8/3279,0.375,7.637422360248447,4.270547263438879,0.00542092976234291,0.052040925718491934,0.041338552105819625,F3/RAC2/CD14,3
WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,3/161,8/3279,0.375,7.637422360248447,4.270547263438879,0.00542092976234291,0.052040925718491934,0.041338552105819625,VEGFA/CDKN1A/MYC,3
WP_UNFOLDED_PROTEIN_RESPONSE,WP_UNFOLDED_PROTEIN_RESPONSE,3/161,8/3279,0.375,7.637422360248447,4.270547263438879,0.00542092976234291,0.052040925718491934,0.041338552105819625,BBC3/TNFRSF10B/IL1B,3
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,13/161,121/3279,0.10743801652892562,2.18813202607669,3.0257335578652462,0.005673569598512499,0.053282218838204345,0.04232456954496738,GADD45B/CCL2/HES1/EGR1/SRGN/IL1B/MYC/SLC2A5/SLC5A12/ANGPTL4/IL12A/THBD/MAFF,13
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,5/161,26/3279,0.19230769230769232,3.91662685140946,3.3923829303913244,0.0076180519620103115,0.06641498727842392,0.05275654447555116,YBX3/TNFRSF10B/CDKN1A/THBS1/SOCS3,5
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,3/161,9/3279,0.3333333333333333,6.788819875776397,3.951088631128318,0.00784065822036949,0.06641498727842392,0.05275654447555116,VEGFA/CDKN1A/IL6,3
WP_HYPERTROPHY_MODEL,WP_HYPERTROPHY_MODEL,3/161,9/3279,0.3333333333333333,6.788819875776397,3.951088631128318,0.00784065822036949,0.06641498727842392,0.05275654447555116,VEGFA/IL1R1/NR4A3,3
WP_SEROTONIN_TRANSPORTER_ACTIVITY,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3/161,9/3279,0.3333333333333333,6.788819875776397,3.951088631128318,0.00784065822036949,0.06641498727842392,0.05275654447555116,IL1R1/IL1B/ITGB3,3
WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,3/161,9/3279,0.3333333333333333,6.788819875776397,3.951088631128318,0.00784065822036949,0.06641498727842392,0.05275654447555116,F3/IL1B/FCGR2A,3
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,4/161,17/3279,0.23529411764705882,4.792108147606869,3.5615787714969542,0.008065027414205454,0.06664619902253346,0.05294020682589158,IRAK3/IL1R1/IL1B/IL6,4
WP_VEGFAVEGFR2_SIGNALING,WP_VEGFAVEGFR2_SIGNALING,16/161,170/3279,0.09411764705882353,1.9168432590427475,2.7892571377690007,0.008176501268968225,0.06664619902253346,0.05294020682589158,PLAUR/CCL2/VEGFA/F3/NR4A3/EGR1/NR4A1/PLA2G5/ALB/ADAMTS9/NOS3/APOLD1/CDH5/TEAD4/PNP/ITGB3,16
WP_APOPTOSIS,WP_APOPTOSIS,6/161,38/3279,0.15789473684210525,3.215756783262504,3.1214309161138867,0.009529606327359198,0.07485072606216679,0.05945744809031768,TNFRSF1A/BBC3/TNFRSF10B/IRF1/MYC/CASP4,6
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,6/161,38/3279,0.15789473684210525,3.215756783262504,3.1214309161138867,0.009529606327359198,0.07485072606216679,0.05945744809031768,GADD45B/GADD45A/CDK2/CDKN1A/MYC/COL4A1,6
WP_IL18_SIGNALING,WP_IL18_SIGNALING,12/161,115/3279,0.10434782608695652,2.125195787199568,2.7908605542376246,0.00977816011091457,0.07543152085562668,0.05991880067966447,TNFRSF1A/CCL2/VEGFA/SPP1/NR4A1/IRF1/IL1B/CD36/IL6/RGS16/ARL4D/SOCS3,12
WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,4/161,18/3279,0.2222222222222222,4.525879917184265,3.4080638884381647,0.009979443029924224,0.07563367348995201,0.06007938001394823,IL1R1/IL1B/IL6/SOCS3,4
WP_4P163_COPY_NUMBER_VARIATION,WP_4P163_COPY_NUMBER_VARIATION,3/161,10/3279,0.3,6.109937888198758,3.676948255198651,0.010801416396534098,0.07908833700513103,0.06282358153916352,FGF2/NELFE/NICOL1,3
WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,3/161,10/3279,0.3,6.109937888198758,3.676948255198651,0.010801416396534098,0.07908833700513103,0.06282358153916352,GADD45A/MYC/PIM1,3
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,7/161,51/3279,0.13725490196078433,2.7953964194373406,2.936013424276119,0.011266546436199924,0.08111913434063946,0.06443673926668729,BBC3/CDK2/IL1B/IL6/TLR2/IL12A/HSPA6,7
WP_COMPLEMENT_AND_COAGULATION_CASCADES,WP_COMPLEMENT_AND_COAGULATION_CASCADES,5/161,29/3279,0.1724137931034483,3.511458556436068,3.0864744882323083,0.012213835644053319,0.08380227858723102,0.06656808679200127,PLAUR/CR2/F3/F12/THBD,5
WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,5/161,29/3279,0.1724137931034483,3.511458556436068,3.0864744882323083,0.012213835644053319,0.08380227858723102,0.06656808679200127,PLAUR/CR2/F3/F12/THBD,5
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,6/161,40/3279,0.15,3.054968944099379,2.9710443983606374,0.012221165627304525,0.08380227858723102,0.06656808679200127,TNFRSF1A/BBC3/CCL2/IL1B/IL6/SOCS3,6
WP_LUNG_PATHOLOGY_OF_COVID19,WP_LUNG_PATHOLOGY_OF_COVID19,3/161,11/3279,0.2727272727272727,5.554488989271598,3.437750329247289,0.014323486863820772,0.09668353633079022,0.07680027496061796,CCL2/IL1B/IL6,3
WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,4/161,20/3279,0.2,4.073291925465839,3.1322469118655603,0.014637784418056549,0.09728496720923738,0.07727801976172365,IL4R/IL6/TLR2/IL12A,4
WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,11/161,108/3279,0.10185185185185185,2.074361628709455,2.5795479362160925,0.015632606743016055,0.10232251686337782,0.08127958210882351,TNFRSF12A/TNFRSF1A/IL4R/CCL2/IL1R1/IL1RL1/TNFRSF10B/INHA/LIF/IL6/CXCR1,11
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,5/161,31/3279,0.16129032258064516,3.2849128431176116,2.9041686475456046,0.01614962401683409,0.10412891903391533,0.08271449221504971,GADD45B/GADD45A/CDKN1A/MYC/FGF2,5
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,4/161,21/3279,0.19047619047619047,3.8793256433007985,3.007490399617255,0.017405520586310553,0.1105762484306788,0.08783590884113376,GADD45A/CDK2/CDKN1A/MYC,4
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,5/161,32/3279,0.15625,3.1822593167701863,2.818509859439648,0.018401444485277686,0.1120773202526402,0.0890282807075066,CCL2/IL1B/IL6/ALB/SERPINA3,5
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,3/161,12/3279,0.25,5.091614906832298,3.226191667504905,0.018420115134114477,0.1120773202526402,0.0890282807075066,HES1/SPP1/CEBPD,3
WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,3/161,12/3279,0.25,5.091614906832298,3.226191667504905,0.018420115134114477,0.1120773202526402,0.0890282807075066,CISH/IL6/SOCS3,3
WP_LEPTIN_SIGNALING,WP_LEPTIN_SIGNALING,4/161,22/3279,0.18181818181818182,3.702992659514399,2.890191933763295,0.020478942368809542,0.1187911716980216,0.09436140831762924,CISH/IL1B/NOS3/SOCS3,4
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,4/161,22/3279,0.18181818181818182,3.702992659514399,2.890191933763295,0.020478942368809542,0.1187911716980216,0.09436140831762924,HES1/SPP1/CDKN1A/CEBPD,4
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,5/161,33/3279,0.15151515151515152,3.0858272162619986,2.736153130673663,0.02085131102334242,0.1187911716980216,0.09436140831762924,GADD45B/CCL2/SRGN/ANGPTL4/THBD,5
WP_TOLLLIKE_RECEPTOR_SIGNALING,WP_TOLLLIKE_RECEPTOR_SIGNALING,6/161,45/3279,0.13333333333333333,2.715527950310559,2.6327729336272165,0.021204195538646647,0.1187911716980216,0.09436140831762924,SPP1/IL1B/IL6/TLR2/IL12A/CD14,6
WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,2/161,5/3279,0.4,8.146583850931679,3.6334862034702513,0.02172338556514747,0.1187911716980216,0.09436140831762924,EGR1/MYC,2
WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,2/161,5/3279,0.4,8.146583850931679,3.6334862034702513,0.02172338556514747,0.1187911716980216,0.09436140831762924,VEGFA/HES1,2
WP_OSTEOPONTIN_SIGNALING,WP_OSTEOPONTIN_SIGNALING,2/161,5/3279,0.4,8.146583850931679,3.6334862034702513,0.02172338556514747,0.1187911716980216,0.09436140831762924,SPP1/ITGB3,2
WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,2/161,5/3279,0.4,8.146583850931679,3.6334862034702513,0.02172338556514747,0.1187911716980216,0.09436140831762924,TEAD3/TEAD4,2
WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,3/161,13/3279,0.23076923076923078,4.699952221691352,3.0369599110981222,0.02309832166941031,0.12022258989379823,0.09549845103649666,IL1B/IL6/IL12A,3
WP_POSTCOVID_NEUROINFLAMMATION,WP_POSTCOVID_NEUROINFLAMMATION,3/161,13/3279,0.23076923076923078,4.699952221691352,3.0369599110981222,0.02309832166941031,0.12022258989379823,0.09549845103649666,IL1B/IL6/IL12A,3
WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,3/161,13/3279,0.23076923076923078,4.699952221691352,3.0369599110981222,0.02309832166941031,0.12022258989379823,0.09549845103649666,IL1B/F12/NOS3,3
WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,3/161,13/3279,0.23076923076923078,4.699952221691352,3.0369599110981222,0.02309832166941031,0.12022258989379823,0.09549845103649666,VEGFA/MYC/HK2,3
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,5/161,34/3279,0.14705882352941177,2.9950675922542933,2.656862500868381,0.023505111891110278,0.12088343258285286,0.096023389429849,IL1B/IL6/PIM1/RUNX1/ITGB3,5
WP_IL1_SIGNALING,WP_IL1_SIGNALING,4/161,23/3279,0.17391304347826086,3.5419929786659465,2.7795559712461926,0.023866098220439717,0.12129593448505832,0.09635105906951515,IRAK3/CCL2/IL1R1/IL1B,4
WP_PEPTIDE_GPCRS,WP_PEPTIDE_GPCRS,6/161,47/3279,0.1276595744680851,2.5999735694462798,2.510183199636048,0.025797761770731956,0.12958875680181633,0.10293843742054612,HCRTR2/CXCR1/FPR2/FPR1/OXTR/ACKR1,6
WP_ATM_SIGNALING,WP_ATM_SIGNALING,3/161,14/3279,0.21428571428571427,4.364241348713398,2.8660840781601156,0.02835964374401072,0.14082029997026013,0.11186017980093764,GADD45A/CDK2/CDKN1A,3
WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,2/161,6/3279,0.3333333333333333,6.788819875776397,3.224571536105223,0.031543659360823956,0.14879710135506605,0.11819652787951151,VEGFA/PDK1,2
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,2/161,6/3279,0.3333333333333333,6.788819875776397,3.224571536105223,0.031543659360823956,0.14879710135506605,0.11819652787951151,CDKN1A/MYC,2
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,2/161,6/3279,0.3333333333333333,6.788819875776397,3.224571536105223,0.031543659360823956,0.14879710135506605,0.11819652787951151,XYLT1/CHST3,2
WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,2/161,6/3279,0.3333333333333333,6.788819875776397,3.224571536105223,0.031543659360823956,0.14879710135506605,0.11819652787951151,PDK1/FPR2,2
WP_MAPK_SIGNALING,WP_MAPK_SIGNALING,11/161,120/3279,0.09166666666666666,1.8669254658385093,2.198249220193428,0.03168827158487517,0.14879710135506605,0.11819652787951151,TNFRSF1A/IL1R1/GADD45A/NR4A1/IL1B/RAC2/MYC/FGF2/CD14/HSPA6/BDNF,11
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,5/161,37/3279,0.13513513513513514,2.7522242739634044,2.4353613334452295,0.032740338061098315,0.15208415099348896,0.12080758582816131,GADD45B/VEGFA/GADD45A/CDKN1A/RAC2,5
WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,3/161,15/3279,0.2,4.073291925465839,2.7105269307401585,0.0342008123913045,0.15717820162812282,0.12485402955840164,CCL2/VEGFA/BAG3,3
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,9/161,92/3279,0.09782608695652174,1.992371050499595,2.1935943844650714,0.03481589070389545,0.15832068193771404,0.12576155534038688,CCL2/EGR1/IL1B/IL6/FGF2/CXCR1/ALB/IL12A/CD14,9
WP_PPAR_SIGNALING,WP_PPAR_SIGNALING,4/161,26/3279,0.15384615384615385,3.1333014811275683,2.481282624981123,0.03596765024142181,0.16018582375561055,0.12724312510801422,SLC27A6/CD36/ANGPTL4/ACSL5,4
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,4/161,26/3279,0.15384615384615385,3.1333014811275683,2.481282624981123,0.03596765024142181,0.16018582375561055,0.12724312510801422,CDK2/CDKN1A/MYC/PLK4,4
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,6/161,52/3279,0.11538461538461539,2.349976110845676,2.2295007850929123,0.04005114442385727,0.17565146031813222,0.13952820678292177,BBC3/CDKN1A/RAC2/MYC/PDK1/FOSL1,6
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,3/161,16/3279,0.1875,3.8187111801242235,2.5679194084026715,0.04061436931243511,0.17565146031813222,0.13952820678292177,TNFRSF12A/CCL2/IL6,3
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,4/161,27/3279,0.14814814814814814,3.017253278122843,2.391367929845045,0.0406600602588269,0.17565146031813222,0.13952820678292177,VEGFA/IL6/FGF2/CXCR1,4
WP_RALA_DOWNSTREAM_REGULATED_GENES,WP_RALA_DOWNSTREAM_REGULATED_GENES,2/161,7/3279,0.2857142857142857,5.818988464951198,2.899863906205751,0.04275551365953589,0.1793240961254321,0.14244555393979255,YBX3/RAC2,2
WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,2/161,7/3279,0.2857142857142857,5.818988464951198,2.899863906205751,0.04275551365953589,0.1793240961254321,0.14244555393979255,EGR2/CEBPD,2
WP_ULCERATIVE_COLITIS_SIGNALING,WP_ULCERATIVE_COLITIS_SIGNALING,2/161,7/3279,0.2857142857142857,5.818988464951198,2.899863906205751,0.04275551365953589,0.1793240961254321,0.14244555393979255,IL4R/TLR2,2
WP_CELL_CYCLE,WP_CELL_CYCLE,5/161,40/3279,0.125,2.545807453416149,2.234906074178642,0.043966625467054245,0.1810974132482545,0.14385418303833086,GADD45B/GADD45A/CDK2/CDKN1A/MYC,5
WP_CANCER_PATHWAYS,WP_CANCER_PATHWAYS,18/161,240/3279,0.075,1.5274844720496894,1.928542915279798,0.044016732386728534,0.1810974132482545,0.14385418303833086,WNT8A/IL4R/EDN1/GADD45B/BBC3/VEGFA/HES1/GADD45A/CDK2/CDKN1A/RAC2/IL6/MYC/PIM1/RUNX1/HEYL/IL12A/COL4A1,18
WP_INFLAMMATORY_RESPONSE_PATHWAY,WP_INFLAMMATORY_RESPONSE_PATHWAY,3/161,17/3279,0.17647058823529413,3.5940811107051522,2.4363820481383924,0.04758922829062721,0.19394855303349956,0.15406244709776037,TNFRSF1A/IL4R/THBS1,3
WP_GENES_CONTROLLING_NEPHROGENESIS,WP_GENES_CONTROLLING_NEPHROGENESIS,3/161,18/3279,0.16666666666666666,3.3944099378881987,2.31440157779139,0.05511118534276781,0.2073614085401329,0.16471690834328295,VEGFA/CD36/GDNF,3
WP_IL2_SIGNALING,WP_IL2_SIGNALING,3/161,18/3279,0.16666666666666666,3.3944099378881987,2.31440157779139,0.05511118534276781,0.2073614085401329,0.16471690834328295,CISH/MYC/SOCS3,3
WP_IL6_SIGNALING,WP_IL6_SIGNALING,3/161,18/3279,0.16666666666666666,3.3944099378881987,2.31440157779139,0.05511118534276781,0.2073614085401329,0.16471690834328295,IRF1/IL6/SOCS3,3
WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,3/161,18/3279,0.16666666666666666,3.3944099378881987,2.31440157779139,0.05511118534276781,0.2073614085401329,0.16471690834328295,IRF1/IL6/MIR758,3
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,3/161,18/3279,0.16666666666666666,3.3944099378881987,2.31440157779139,0.05511118534276781,0.2073614085401329,0.16471690834328295,CISH/IL6/MYC,3
WP_TYPE_II_INTERFERON_SIGNALING,WP_TYPE_II_INTERFERON_SIGNALING,3/161,18/3279,0.16666666666666666,3.3944099378881987,2.31440157779139,0.05511118534276781,0.2073614085401329,0.16471690834328295,IRF1/IL1B/SOCS3,3
WP_BLOOD_CLOTTING_CASCADE,WP_BLOOD_CLOTTING_CASCADE,2/161,8/3279,0.25,5.091614906832298,2.632563349903251,0.055200374958600196,0.2073614085401329,0.16471690834328295,F3/F12,2
WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,2/161,8/3279,0.25,5.091614906832298,2.632563349903251,0.055200374958600196,0.2073614085401329,0.16471690834328295,NR4A1/ITPRIP,2
WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,2/161,8/3279,0.25,5.091614906832298,2.632563349903251,0.055200374958600196,0.2073614085401329,0.16471690834328295,IL1B/IL6,2
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,12/161,149/3279,0.08053691275167785,1.6402517820667804,1.817402489380784,0.059549562418404624,0.22177078417888618,0.17616295234482676,IL4R/OSM/VEGFA/SPP1/CDKN1A/THBS1/FGF2/OSMR/NOS3/EFNA1/COL4A1/ITGB3,12
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,7/161,72/3279,0.09722222222222222,1.980072463768116,1.9105319852116116,0.061018387307425856,0.22184212055789143,0.1762196181819508,GADD45B/HES1/GADD45A/CDKN1A/MYC/FGF2/HEYL,7
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,6/161,58/3279,0.10344827586206896,2.1068751338616405,1.9323981926971832,0.06273741522999265,0.22184212055789143,0.1762196181819508,CCL2/VEGFA/IL1B/IL6/TLR2/S100A9,6
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,6/161,58/3279,0.10344827586206896,2.1068751338616405,1.9323981926971832,0.06273741522999265,0.22184212055789143,0.1762196181819508,TEAD3/CD44/MYC/CDH5/TEAD4/ITGB3,6
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,3/161,19/3279,0.15789473684210525,3.215756783262504,2.200743587893834,0.06316338154773297,0.22184212055789143,0.1762196181819508,HES1/IL1B/IL12A,3
WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,3/161,19/3279,0.15789473684210525,3.215756783262504,2.200743587893834,0.06316338154773297,0.22184212055789143,0.1762196181819508,GABRE/GABRA6/BDNF,3
WP_MONOAMINE_TRANSPORT,WP_MONOAMINE_TRANSPORT,3/161,19/3279,0.15789473684210525,3.215756783262504,2.200743587893834,0.06316338154773297,0.22184212055789143,0.1762196181819508,IL1R1/IL1B/ITGB3,3
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,3/161,19/3279,0.15789473684210525,3.215756783262504,2.200743587893834,0.06316338154773297,0.22184212055789143,0.1762196181819508,SPP1/LIF/THBS1,3
WP_BDNFTRKB_SIGNALING,WP_BDNFTRKB_SIGNALING,2/161,9/3279,0.2222222222222222,4.525879917184265,2.4065464731085573,0.06873172259809467,0.23379609576674723,0.1857152222708567,BDNF/ARC,2
WP_OSTEOCLAST_SIGNALING,WP_OSTEOCLAST_SIGNALING,2/161,9/3279,0.2222222222222222,4.525879917184265,2.4065464731085573,0.06873172259809467,0.23379609576674723,0.1857152222708567,SPP1/ITGB3,2
WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,2/161,9/3279,0.2222222222222222,4.525879917184265,2.4065464731085573,0.06873172259809467,0.23379609576674723,0.1857152222708567,IL6/COL4A1,2
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,2/161,9/3279,0.2222222222222222,4.525879917184265,2.4065464731085573,0.06873172259809467,0.23379609576674723,0.1857152222708567,IRAK3/IL6,2
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,3/161,20/3279,0.15,3.054968944099379,2.094389431670818,0.07172672221767576,0.2347419999851207,0.18646659842872645,CCL2/IL6/CD14,3
WP_IL26_SIGNALING,WP_IL26_SIGNALING,3/161,20/3279,0.15,3.054968944099379,2.094389431670818,0.07172672221767576,0.2347419999851207,0.18646659842872645,IL1B/IL6/SOCS3,3
WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,3/161,20/3279,0.15,3.054968944099379,2.094389431670818,0.07172672221767576,0.2347419999851207,0.18646659842872645,VEGFA/CDK2/CDH5,3
WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,3/161,20/3279,0.15,3.054968944099379,2.094389431670818,0.07172672221767576,0.2347419999851207,0.18646659842872645,EDN1/VEGFA/BCL2A1,3
WP_SLEEP_REGULATION,WP_SLEEP_REGULATION,3/161,20/3279,0.15,3.054968944099379,2.094389431670818,0.07172672221767576,0.2347419999851207,0.18646659842872645,IL6/HCRTR2/OXTR,3
WP_PROLACTIN_SIGNALING,WP_PROLACTIN_SIGNALING,4/161,33/3279,0.12121212121212122,2.468661773009599,1.9265658616356787,0.07571906654419937,0.24289579210909104,0.19294353856618832,CISH/IRF1/MYC/SOCS3,4
WP_NOTCH_SIGNALING_WP61,WP_NOTCH_SIGNALING_WP61,3/161,21/3279,0.14285714285714285,2.909494232475599,1.9944897811945559,0.08078025582290341,0.24289579210909104,0.19294353856618832,HES1/CDKN1A/MYC,3
WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,3/161,21/3279,0.14285714285714285,2.909494232475599,1.9944897811945559,0.08078025582290341,0.24289579210909104,0.19294353856618832,IL1B/LIF/FGF2,3
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,4/161,34/3279,0.11764705882352941,2.3960540738034344,1.859146894207139,0.08268092716461126,0.24289579210909104,0.19294353856618832,VEGFA/IL1B/GDNF/IL12A,4
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,4/161,34/3279,0.11764705882352941,2.3960540738034344,1.859146894207139,0.08268092716461126,0.24289579210909104,0.19294353856618832,GADD45B/GADD45A/CDKN1A/PDK1,4
WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,IL1B/IL6,2
WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,MPZL2/ZIC1,2
WP_EPO_RECEPTOR_SIGNALING,WP_EPO_RECEPTOR_SIGNALING,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,CISH/PDK1,2
WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,SPP1/IL6,2
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,SPP1/CDKN1A,2
WP_IL19_SIGNALING,WP_IL19_SIGNALING,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,TNFRSF1A/IL4R,2
WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,MYC/FOSL1,2
WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,BBC3/TNFRSF10B,2
WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,MYC/IL12A,2
WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,MYC/BCL2A1,2
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,2/161,10/3279,0.2,4.073291925465839,2.211442806214042,0.0832142991484849,0.24289579210909104,0.19294353856618832,VEGFA/CDKN1A,2
WP_GASTRIN_SIGNALING,WP_GASTRIN_SIGNALING,5/161,48/3279,0.10416666666666667,2.121506211180124,1.7784152755454326,0.08395953122393758,0.2434262918707452,0.19336493944898378,CD44/VEGFA/EGR1/CDKN1A/MYC,5
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,4/161,35/3279,0.11428571428571428,2.327595385980479,1.7940671367264762,0.08994709019715036,0.25834605856775744,0.20521641104553834,VEGFA/IL6/MYC/FGF2,4
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,3/161,22/3279,0.13636363636363635,2.777244494635799,1.9003298749780595,0.09030151584197077,0.25834605856775744,0.20521641104553834,SPP1/LIF/THBS1,3
WP_FATTY_ACID_TRANSPORTERS,WP_FATTY_ACID_TRANSPORTERS,2/161,11/3279,0.18181818181818182,3.702992659514399,2.0402319397603237,0.09852336854507684,0.27242308116733716,0.21639845141460023,CD36/ACSL5,2
WP_HIPPOYAP_SIGNALING,WP_HIPPOYAP_SIGNALING,2/161,11/3279,0.18181818181818182,3.702992659514399,2.0402319397603237,0.09852336854507684,0.27242308116733716,0.21639845141460023,TEAD3/TEAD4,2
WP_IRON_METABOLISM_DISORDERS,WP_IRON_METABOLISM_DISORDERS,2/161,11/3279,0.18181818181818182,3.702992659514399,2.0402319397603237,0.09852336854507684,0.27242308116733716,0.21639845141460023,CP/HAMP,2
WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,2/161,11/3279,0.18181818181818182,3.702992659514399,2.0402319397603237,0.09852336854507684,0.27242308116733716,0.21639845141460023,CDKN1A/PLA2G5,2
WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,2/161,11/3279,0.18181818181818182,3.702992659514399,2.0402319397603237,0.09852336854507684,0.27242308116733716,0.21639845141460023,TNFRSF1A/CD36,2
WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,3/161,23/3279,0.13043478260869565,2.65649473399946,1.8113031262747419,0.1002668284852005,0.27242308116733716,0.21639845141460023,VEGFA/SPP1/FOSL1,3
WP_OXIDATIVE_DAMAGE_RESPONSE,WP_OXIDATIVE_DAMAGE_RESPONSE,3/161,23/3279,0.13043478260869565,2.65649473399946,1.8113031262747419,0.1002668284852005,0.27242308116733716,0.21639845141460023,GADD45A/CR2/CDKN1A,3
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,3/161,23/3279,0.13043478260869565,2.65649473399946,1.8113031262747419,0.1002668284852005,0.27242308116733716,0.21639845141460023,TNFRSF1A/CDKN1A/IL6,3
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,4/161,37/3279,0.10810810810810811,2.2017794191707236,1.670315365600153,0.10536067417457293,0.2827069021330156,0.22456737352671316,VEGFA/SPP1/FGF2/ADAMTS4,4
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,4/161,37/3279,0.10810810810810811,2.2017794191707236,1.670315365600153,0.10536067417457293,0.2827069021330156,0.22456737352671316,VEGFA/SPP1/FGF2/ADAMTS4,4
WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,3/161,24/3279,0.125,2.545807453416149,1.726890811153811,0.11065158903101609,0.2910765665069432,0.23121579113368296,CCL2/TBC1D3/MRPL45,3
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,3/161,24/3279,0.125,2.545807453416149,1.726890811153811,0.11065158903101609,0.2910765665069432,0.23121579113368296,TEAD3/TEAD4/ITGB3,3
WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,4/161,38/3279,0.10526315789473684,2.1438378555083357,1.6113730857896855,0.11349050459552112,0.2910765665069432,0.23121579113368296,CDK2/CDKN1A/IL6/H4C2,4
WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,2/161,12/3279,0.16666666666666666,3.3944099378881987,1.8879649151015423,0.11454401922726933,0.2910765665069432,0.23121579113368296,SELPLG/IL6,2
WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,2/161,12/3279,0.16666666666666666,3.3944099378881987,1.8879649151015423,0.11454401922726933,0.2910765665069432,0.23121579113368296,CDK2/MYC,2
WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,2/161,12/3279,0.16666666666666666,3.3944099378881987,1.8879649151015423,0.11454401922726933,0.2910765665069432,0.23121579113368296,IL6/IL12A,2
WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,2/161,12/3279,0.16666666666666666,3.3944099378881987,1.8879649151015423,0.11454401922726933,0.2910765665069432,0.23121579113368296,IL4R/IL12A,2
WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,2/161,12/3279,0.16666666666666666,3.3944099378881987,1.8879649151015423,0.11454401922726933,0.2910765665069432,0.23121579113368296,CDK2/CDKN1A,2
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,2/161,12/3279,0.16666666666666666,3.3944099378881987,1.8879649151015423,0.11454401922726933,0.2910765665069432,0.23121579113368296,IL6/CEBPD,2
WP_CCL18_SIGNALING,WP_CCL18_SIGNALING,3/161,25/3279,0.12,2.443975155279503,1.646646245139011,0.12143050931937496,0.3026224485950176,0.24038722768512602,CD44/MYC/TEAD4,3
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,4/161,39/3279,0.10256410256410256,2.0888676540850453,1.5542262957533444,0.12188959735077096,0.3026224485950176,0.24038722768512602,EDN1/RAC2/IL6/IL12A,4
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,4/161,39/3279,0.10256410256410256,2.0888676540850453,1.5542262957533444,0.12188959735077096,0.3026224485950176,0.24038722768512602,EDN1/CISH/LIF/FGF2,4
WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,4/161,39/3279,0.10256410256410256,2.0888676540850453,1.5542262957533444,0.12188959735077096,0.3026224485950176,0.24038722768512602,TNFRSF1A/CCL2/IL6/TLR2,4
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,5/161,54/3279,0.09259259259259259,1.8857832988267769,1.491210198416961,0.12325746986700073,0.3042698684716818,0.24169585068656987,WNT8A/HES1/MYC/FGF2/ZIC1,5
WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,2/161,13/3279,0.15384615384615385,3.1333014811275683,1.751036415683512,0.13117050969233454,0.3164288748408208,0.2513543206581569,TNFRSF1A/PDK1,2
WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,2/161,13/3279,0.15384615384615385,3.1333014811275683,1.751036415683512,0.13117050969233454,0.3164288748408208,0.2513543206581569,IL4R/CCL2,2
WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,2/161,13/3279,0.15384615384615385,3.1333014811275683,1.751036415683512,0.13117050969233454,0.3164288748408208,0.2513543206581569,SLC1A5/SLC16A3,2
WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,2/161,13/3279,0.15384615384615385,3.1333014811275683,1.751036415683512,0.13117050969233454,0.3164288748408208,0.2513543206581569,TEAD3/TEAD4,2
WP_MELANOMA,WP_MELANOMA,3/161,26/3279,0.11538461538461539,2.349976110845676,1.570182319570921,0.13257783876432536,0.3164288748408208,0.2513543206581569,GADD45B/GADD45A/CDKN1A,3
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,3/161,26/3279,0.11538461538461539,2.349976110845676,1.570182319570921,0.13257783876432536,0.3164288748408208,0.2513543206581569,EGR1/CDK2/MYC,3
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,7/161,88/3279,0.07954545454545454,1.6200592885375493,1.339647410161517,0.1387254614190723,0.329282413917798,0.2615644905877245,IL1B/IL6/RGS16/ADM/NOS3/OXTR/MAFF,7
WP_PREIMPLANTATION_EMBRYO,WP_PREIMPLANTATION_EMBRYO,3/161,27/3279,0.1111111111111111,2.2629399585921326,1.4971615845420567,0.14406756107751265,0.34009391467478395,0.2701525735477085,EGR1/ZFP36/TEAD4,3
WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,2/161,14/3279,0.14285714285714285,2.909494232475599,1.6267474445999126,0.14830565401705526,0.34631374343442095,0.2750932757300712,IL6/ARID5A,2
WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,2/161,14/3279,0.14285714285714285,2.909494232475599,1.6267474445999126,0.14830565401705526,0.34631374343442095,0.2750932757300712,PDK1/NOS3,2
WP_ENDOTHELIN_PATHWAYS,WP_ENDOTHELIN_PATHWAYS,2/161,15/3279,0.13333333333333333,2.715527950310559,1.513030594726014,0.16586024503640154,0.37910913151177494,0.30114419315993823,EDN1/NOS3,2
WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,2/161,15/3279,0.13333333333333333,2.715527950310559,1.513030594726014,0.16586024503640154,0.37910913151177494,0.30114419315993823,TEAD3/TEAD4,2
WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,2/161,15/3279,0.13333333333333333,2.715527950310559,1.513030594726014,0.16586024503640154,0.37910913151177494,0.30114419315993823,THBS1/COL4A1,2
WP_OVARIAN_INFERTILITY,WP_OVARIAN_INFERTILITY,2/161,15/3279,0.13333333333333333,2.715527950310559,1.513030594726014,0.16586024503640154,0.37910913151177494,0.30114419315993823,EGR1/INHA,2
WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,3/161,29/3279,0.10344827586206896,2.1068751338616405,1.3603019064629516,0.167969817075918,0.38191032093050825,0.3033693095110763,FGF2/BDNF/CEBPD,3
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,5/161,61/3279,0.08196721311475409,1.6693819366663272,1.1990167317621914,0.1779008300735823,0.40237255807218614,0.31962342575909525,EGR2/CDKN1A/IL6/MYC/TLR2,5
WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,3/161,30/3279,0.1,2.0366459627329196,1.2959719135025427,0.1803304597674672,0.4057435344768012,0.3223011506808899,HES1/MYC/BDNF,3
WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,2/161,16/3279,0.125,2.545807453416149,1.4082709109295466,0.18375251299696818,0.4091808536839704,0.3250315748074423,SLC1A5/CD36,2
WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,2/161,16/3279,0.125,2.545807453416149,1.4082709109295466,0.18375251299696818,0.4091808536839704,0.3250315748074423,PIM1/PDK1,2
WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,4/161,46/3279,0.08695652173913043,1.7709964893329733,1.196486550849997,0.18731153684482704,0.4149670970100784,0.32962785971073477,CR2/IL6/IL12A/NEAT1,4
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,3/161,31/3279,0.0967741935483871,1.970947705870567,1.2340934116104874,0.1929299672729346,0.42523339725463133,0.3377828642909596,PLAUR/CDKN1A/ITGB3,3
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,4/161,48/3279,0.08333333333333333,1.6972049689440993,1.105584574205468,0.2077834256262751,0.44328921135099125,0.3521254456637991,PDK1/BDNF/ARC/CYFIP1,4
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,5/161,65/3279,0.07692307692307693,1.5666507405637842,1.0484037362724612,0.21261580426408097,0.44328921135099125,0.3521254456637991,SPP1/EGR1/EGR2/BDNF/CYFIP1,5
WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,2/161,18/3279,0.1111111111111111,2.2629399585921326,1.2207392671446156,0.22025717165969425,0.44328921135099125,0.3521254456637991,TLR2/FCGR2A,2
WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,2/161,18/3279,0.1111111111111111,2.2629399585921326,1.2207392671446156,0.22025717165969425,0.44328921135099125,0.3521254456637991,ARC/CYFIP1,2
WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,2/161,18/3279,0.1111111111111111,2.2629399585921326,1.2207392671446156,0.22025717165969425,0.44328921135099125,0.3521254456637991,HES1/FGF2,2
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,2/161,18/3279,0.1111111111111111,2.2629399585921326,1.2207392671446156,0.22025717165969425,0.44328921135099125,0.3521254456637991,EGR2/CEBPD,2
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,6/161,83/3279,0.07228915662650602,1.4722741899274114,0.9901687821086238,0.2209308898387292,0.44328921135099125,0.3521254456637991,VEGFA/HES1/EGR1/IL1B/IL6/BDNF,6
WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,5/161,66/3279,0.07575757575757576,1.5429136081309993,1.0123406815242821,0.221620620137844,0.44328921135099125,0.3521254456637991,GABRE/IL1B/IL6/GABRA6/BDNF,5
WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,SLC1A5,1
WP_EFFECTS_OF_NITRIC_OXIDE,WP_EFFECTS_OF_NITRIC_OXIDE,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,NOS3,1
WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,MAFF,1
WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,PDK1,1
WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,HAMP,1
WP_ID_SIGNALING,WP_ID_SIGNALING,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,CDK2,1
WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,BDNF,1
WP_LEPTININSULIN_SIGNALING_OVERLAP,WP_LEPTININSULIN_SIGNALING_OVERLAP,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,SOCS3,1
WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,CDKN1A,1
WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,ALOX12B,1
WP_PURINE_METABOLISM,WP_PURINE_METABOLISM,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,PNP,1
WP_TCA_CYCLE_IN_SENESCENCE,WP_TCA_CYCLE_IN_SENESCENCE,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,PDK1,1
WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,1/161,5/3279,0.2,4.073291925465839,1.5625316995281422,0.22267073810917848,0.44328921135099125,0.3521254456637991,IL6,1
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,4/161,50/3279,0.08,1.6293167701863354,1.0188251144386686,0.2288676513490937,0.45353589625141505,0.36026486885468156,EGR1/SLC2A5/SLC5A12/MAFF,4
WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,2/161,19/3279,0.10526315789473684,2.1438378555083357,1.136087609035191,0.23873879402580733,0.4709367991741953,0.3740872235155645,SLC2A5/HK2,2
WP_GABA_RECEPTOR_SIGNALING,WP_GABA_RECEPTOR_SIGNALING,2/161,20/3279,0.1,2.0366459627329196,1.0565319514760751,0.2572956908933776,0.48372162432198595,0.384242810743098,GABRE/GABRA6,2
WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,2/161,20/3279,0.1,2.0366459627329196,1.0565319514760751,0.2572956908933776,0.48372162432198595,0.384242810743098,CD14/TUBB6,2
WP_6Q16_COPY_NUMBER_VARIATION,WP_6Q16_COPY_NUMBER_VARIATION,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,BDNF,1
WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,TLR2,1
WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,NOS3,1
WP_FOXP3_IN_COVID19,WP_FOXP3_IN_COVID19,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,IL6,1
WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,HES1,1
WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,ITGB3,1
WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,TNFRSF1A,1
WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,PLA2G5,1
WP_OSTEOBLAST_SIGNALING,WP_OSTEOBLAST_SIGNALING,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,ITGB3,1
WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,BBC3,1
WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,TNFRSF1A,1
WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,1/161,6/3279,0.16666666666666666,3.3944099378881987,1.3337685913825787,0.2608961538588489,0.48372162432198595,0.384242810743098,IL6,1
WP_FERROPTOSIS,WP_FERROPTOSIS,3/161,37/3279,0.08108108108108109,1.6513345643780428,0.9052693977550768,0.272176561672763,0.4965772734109059,0.39445465675427716,CP/SLC1A5/ACSL5,3
WP_METABOLIC_EPILEPTIC_DISORDERS,WP_METABOLIC_EPILEPTIC_DISORDERS,3/161,37/3279,0.08108108108108109,1.6513345643780428,0.9052693977550768,0.272176561672763,0.4965772734109059,0.39445465675427716,SLC1A5/SLC2A5/HK2,3
WP_UROTENSINIIMEDIATED_SIGNALING,WP_UROTENSINIIMEDIATED_SIGNALING,3/161,37/3279,0.08108108108108109,1.6513345643780428,0.9052693977550768,0.272176561672763,0.4965772734109059,0.39445465675427716,CDK2/IL1B/IL6,3
WP_IL4_SIGNALING,WP_IL4_SIGNALING,2/161,21/3279,0.09523809523809523,1.9396628216503993,0.9814891627718563,0.27587626300605883,0.4965772734109059,0.39445465675427716,IL4R/SOCS3,2
WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,2/161,21/3279,0.09523809523809523,1.9396628216503993,0.9814891627718563,0.27587626300605883,0.4965772734109059,0.39445465675427716,SLC1A5/HK2,2
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,2/161,21/3279,0.09523809523809523,1.9396628216503993,0.9814891627718563,0.27587626300605883,0.4965772734109059,0.39445465675427716,CCL2/IL6,2
WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,2/161,21/3279,0.09523809523809523,1.9396628216503993,0.9814891627718563,0.27587626300605883,0.4965772734109059,0.39445465675427716,BDNF/ARC,2
WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,4/161,55/3279,0.07272727272727272,1.4811970638057594,0.8176852318461636,0.28361474156371813,0.5075623105192619,0.4031805877906418,HAMP/HES1/IL1B/ITGB3,4
WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,3/161,38/3279,0.07894736842105263,1.607878391631252,0.856344170627585,0.2857782237079552,0.5075623105192619,0.4031805877906418,NR4A1/NOS3/FOSL1,3
WP_TNFALPHA_SIGNALING,WP_TNFALPHA_SIGNALING,3/161,38/3279,0.07894736842105263,1.607878391631252,0.856344170627585,0.2857782237079552,0.5075623105192619,0.4031805877906418,TNFRSF1A/CCL2/IL6,3
WP_APOPTOSIS_MODULATION_BY_HSP70,WP_APOPTOSIS_MODULATION_BY_HSP70,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,TNFRSF1A,1
WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,TYMP,1
WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,IL12A,1
WP_ESTROGEN_METABOLISM_WP697,WP_ESTROGEN_METABOLISM_WP697,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,ARSL,1
WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,PDK1,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,BBC3,1
WP_IL10_ANTIINFLAMMATORY_SIGNALING,WP_IL10_ANTIINFLAMMATORY_SIGNALING,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,IL6,1
WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,IRF1,1
WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,MYC,1
WP_PPARALPHA_PATHWAY,WP_PPARALPHA_PATHWAY,1/161,7/3279,0.14285714285714285,2.909494232475599,1.1490530521367661,0.2972529272254011,0.5075623105192619,0.4031805877906418,MYC,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,4/161,57/3279,0.07017543859649122,1.4292252370055571,0.7427441948189543,0.30607803670851647,0.5205736687325949,0.41351612087433226,CCL2/MYC/PIM1/STC1,4
WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,2/161,23/3279,0.08695652173913043,1.7709964893329733,0.8430502813032912,0.3129258243164931,0.5260076113024319,0.41783255673633735,XYLT1/CHST3,2
WP_OPIOID_RECEPTOR_PATHWAYS,WP_OPIOID_RECEPTOR_PATHWAYS,2/161,23/3279,0.08695652173913043,1.7709964893329733,0.8430502813032912,0.3129258243164931,0.5260076113024319,0.41783255673633735,BDNF/ARC,2
WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,2/161,23/3279,0.08695652173913043,1.7709964893329733,0.8430502813032912,0.3129258243164931,0.5260076113024319,0.41783255673633735,HSPA6/TUBB6,2
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,2/161,24/3279,0.08333333333333333,1.6972049689440993,0.7788789293903177,0.33131439116062755,0.5348931527232792,0.42489075971683476,TNFRSF1A/FGF2,2
WP_PYRIMIDINE_METABOLISM,WP_PYRIMIDINE_METABOLISM,2/161,24/3279,0.08333333333333333,1.6972049689440993,0.7788789293903177,0.33131439116062755,0.5348931527232792,0.42489075971683476,TYMP/POLR2A,2
WP_FATTY_ACID_BIOSYNTHESIS,WP_FATTY_ACID_BIOSYNTHESIS,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,ACSL5,1
WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,BDNF,1
WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,GPRC5A,1
WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,MYC,1
WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,ITGB3,1
WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,IL6,1
WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,PNP,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,VEGFA,1
WP_SULFATASE_AND_AROMATASE_PATHWAY,WP_SULFATASE_AND_AROMATASE_PATHWAY,1/161,8/3279,0.125,2.545807453416149,0.9945794363676229,0.33183186326351577,0.5348931527232792,0.42489075971683476,SLCO4A1,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,2/161,25/3279,0.08,1.6293167701863354,0.7176453783443074,0.3495651634946496,0.548985270124639,0.4360847905960827,HAMP/MYC,2
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,2/161,25/3279,0.08,1.6293167701863354,0.7176453783443074,0.3495651634946496,0.548985270124639,0.4360847905960827,IL1B/IL6,2
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,2/161,25/3279,0.08,1.6293167701863354,0.7176453783443074,0.3495651634946496,0.548985270124639,0.4360847905960827,VEGFA/CDKN1A,2
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,2/161,25/3279,0.08,1.6293167701863354,0.7176453783443074,0.3495651634946496,0.548985270124639,0.4360847905960827,IL1R1/MYC,2
WP_NETRINUNC5B_SIGNALING,WP_NETRINUNC5B_SIGNALING,2/161,25/3279,0.08,1.6293167701863354,0.7176453783443074,0.3495651634946496,0.548985270124639,0.4360847905960827,CCL2/CDH5,2
WP_HIPPO_SIGNALING_REGULATION,WP_HIPPO_SIGNALING_REGULATION,3/161,43/3279,0.06976744186046512,1.4209157879531995,0.6312545832467421,0.35424521100479023,0.548985270124639,0.4360847905960827,TEAD3/CDH5/TEAD4,3
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,6/161,99/3279,0.06060606060606061,1.2343308865047995,0.5379141021296288,0.3584601309630695,0.548985270124639,0.4360847905960827,VEGFA/SPP1/RAC2/THBS1/COL4A1/ITGB3,6
WP_16P112_DISTAL_DELETION_SYNDROME,WP_16P112_DISTAL_DELETION_SYNDROME,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,CR2,1
WP_ACE_INHIBITOR_PATHWAY,WP_ACE_INHIBITOR_PATHWAY,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,NOS3,1
WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,MTHFD2,1
WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,BDNF,1
WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,POLR2A,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,ANGPTL4,1
WP_IRON_METABOLISM_IN_PLACENTA,WP_IRON_METABOLISM_IN_PLACENTA,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,HAMP,1
WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,SLC16A3,1
WP_LIPID_METABOLISM_PATHWAY,WP_LIPID_METABOLISM_PATHWAY,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,HILPDA,1
WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,TYMP,1
WP_RETINOL_METABOLISM,WP_RETINOL_METABOLISM,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,BCO1,1
WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,1/161,9/3279,0.1111111111111111,2.2629399585921326,0.8620043150887962,0.3647193808466931,0.548985270124639,0.4360847905960827,EGR1,1
WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,2/161,26/3279,0.07692307692307693,1.5666507405637842,0.6590820141607193,0.3676474405555097,0.5495629561244989,0.4365436737246263,IL1B/NOS3,2
WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,2/161,26/3279,0.07692307692307693,1.5666507405637842,0.6590820141607193,0.3676474405555097,0.5495629561244989,0.4365436737246263,VEGFA/IL6,2
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,2/161,27/3279,0.07407407407407407,1.5086266390614216,0.6029552392390688,0.3855338309137496,0.5743124653611719,0.45620337160755847,CDKN1A/IL12A,2
WP_B_CELL_RECEPTOR_SIGNALING,WP_B_CELL_RECEPTOR_SIGNALING,3/161,46/3279,0.06521739130434782,1.32824736699973,0.5093973388995346,0.39506720486291935,0.5779426231327213,0.4590869764650759,CR2/RAC2/MYC,3
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,3/161,46/3279,0.06521739130434782,1.32824736699973,0.5093973388995346,0.39506720486291935,0.5779426231327213,0.4590869764650759,CR2/PLSCR1/ITGB3,3
WP_IL7_SIGNALING,WP_IL7_SIGNALING,1/161,10/3279,0.1,2.0366459627329196,0.7459373572294333,0.3959977232576053,0.5779426231327213,0.4590869764650759,MYC,1
WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1/161,10/3279,0.1,2.0366459627329196,0.7459373572294333,0.3959977232576053,0.5779426231327213,0.4590869764650759,CP,1
WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,1/161,10/3279,0.1,2.0366459627329196,0.7459373572294333,0.3959977232576053,0.5779426231327213,0.4590869764650759,VEGFA,1
WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,1/161,10/3279,0.1,2.0366459627329196,0.7459373572294333,0.3959977232576053,0.5779426231327213,0.4590869764650759,ARC,1
WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,2/161,28/3279,0.07142857142857142,1.4547471162377994,0.5490600456106849,0.40320000492745656,0.585738562327601,0.4652796572095467,CD36/BCO1,2
WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,2/161,29/3279,0.06896551724137931,1.4045834225744271,0.4972156155782731,0.42062446328683,0.585738562327601,0.4652796572095467,VANGL1/C11orf96,2
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,2/161,29/3279,0.06896551724137931,1.4045834225744271,0.4972156155782731,0.42062446328683,0.585738562327601,0.4652796572095467,MYC/CLDN5,2
WP_ANDROGEN_RECEPTOR_SIGNALING,WP_ANDROGEN_RECEPTOR_SIGNALING,2/161,29/3279,0.06896551724137931,1.4045834225744271,0.4972156155782731,0.42062446328683,0.585738562327601,0.4652796572095467,CDKN1A/LIMK2,2
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,2/161,29/3279,0.06896551724137931,1.4045834225744271,0.4972156155782731,0.42062446328683,0.585738562327601,0.4652796572095467,VEGFA/HK2,2
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,3/161,48/3279,0.0625,1.2729037267080745,0.43275387286550326,0.42192387648016305,0.585738562327601,0.4652796572095467,HES1/POLR2A/CLDN5,3
WP_WNT_SIGNALING_AND_PLURIPOTENCY,WP_WNT_SIGNALING_AND_PLURIPOTENCY,3/161,48/3279,0.0625,1.2729037267080745,0.43275387286550326,0.42192387648016305,0.585738562327601,0.4652796572095467,CD44/MYC/FOSL1,3
WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,VEGFA,1
WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,F12,1
WP_EICOSANOID_SYNTHESIS,WP_EICOSANOID_SYNTHESIS,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,PLA2G5,1
WP_FATTY_ACID_BETAOXIDATION,WP_FATTY_ACID_BETAOXIDATION,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,ACSL5,1
WP_FLUOROPYRIMIDINE_ACTIVITY,WP_FLUOROPYRIMIDINE_ACTIVITY,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,TYMP,1
WP_GASTRIC_CANCER_NETWORK_2,WP_GASTRIC_CANCER_NETWORK_2,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,MYC,1
WP_GDNFRET_SIGNALING_AXIS,WP_GDNFRET_SIGNALING_AXIS,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,GDNF,1
WP_IL17_SIGNALING,WP_IL17_SIGNALING,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,CEBPD,1
WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,NELFE,1
WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,CDKN1A,1
WP_MRNA_PROCESSING,WP_MRNA_PROCESSING,1/161,11/3279,0.09090909090909091,1.8514963297571996,0.6427135502733586,0.4257451587288582,0.585738562327601,0.4652796572095467,POLR2A,1
WP_GPCRS_OTHER,WP_GPCRS_OTHER,3/161,49/3279,0.061224489795918366,1.2469260996323996,0.3956791194541705,0.4352066185066049,0.5968547910947725,0.4741097999437033,ADGRE2/CXCR1/ACKR1,3
WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,2/161,30/3279,0.06666666666666667,1.3577639751552795,0.44726172688883437,0.4377883206810701,0.5984954257412097,0.4754130331180175,RAC2/FCGR1A,2
WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,3/161,50/3279,0.06,1.2219875776397515,0.35938422414170956,0.44837719087836103,0.6016675645689402,0.47793281201139015,SLC1A5/SPP1/GAL3ST4,3
WP_GPCRS_CLASS_A_RHODOPSINLIKE,WP_GPCRS_CLASS_A_RHODOPSINLIKE,7/161,129/3279,0.05426356589147287,1.1051567239635995,0.2768573025239295,0.44942210266108173,0.6016675645689402,0.47793281201139015,HCRTR2/GPR6/CXCR1/FPR2/FPR1/GPR4/OXTR,7
WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,CDK2,1
WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,FPR2,1
WP_IL11_SIGNALING,WP_IL11_SIGNALING,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,SOCS3,1
WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,TNFRSF1A,1
WP_SILDENAFIL_TREATMENT,WP_SILDENAFIL_TREATMENT,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,NOS3,1
WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,PDK1,1
WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,TLR2,1
WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,1/161,12/3279,0.08333333333333333,1.6972049689440993,0.5497381626981793,0.45403617141082064,0.6016675645689402,0.47793281201139015,MYC,1
WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,2/161,32/3279,0.0625,1.2729037267080745,0.3524704138016672,0.4712705619330507,0.6183535412837503,0.49118726719908035,SPP1/IL6,2
WP_GLIOBLASTOMA_SIGNALING,WP_GLIOBLASTOMA_SIGNALING,2/161,32/3279,0.0625,1.2729037267080745,0.3524704138016672,0.4712705619330507,0.6183535412837503,0.49118726719908035,CDK2/CDKN1A,2
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,2/161,32/3279,0.0625,1.2729037267080745,0.3524704138016672,0.4712705619330507,0.6183535412837503,0.49118726719908035,CDKN1A/MYC,2
WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,HES1,1
WP_DNA_REPLICATION,WP_DNA_REPLICATION,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,CDK2,1
WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,EGR2,1
WP_MELATONIN_METABOLISM_AND_EFFECTS,WP_MELATONIN_METABOLISM_AND_EFFECTS,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,EDN1,1
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,CDKN1A,1
WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,TLR2,1
WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,1/161,13/3279,0.07692307692307693,1.5666507405637842,0.4651129202689015,0.48094164322069466,0.6183535412837503,0.49118726719908035,EDN1,1
WP_5Q35_COPY_NUMBER_VARIATION,WP_5Q35_COPY_NUMBER_VARIATION,2/161,33/3279,0.06060606060606061,1.2343308865047995,0.30739132355971033,0.4875624919851459,0.6250059244438666,0.49647156766252565,F12/MYC,2
WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/161,14/3279,0.07142857142857142,1.4547471162377994,0.38741081103970965,0.50652902700559,0.641702462364853,0.509734412112432,TNFRSF1A,1
WP_ONECARBON_METABOLISM,WP_ONECARBON_METABOLISM,1/161,14/3279,0.07142857142857142,1.4547471162377994,0.38741081103970965,0.50652902700559,0.641702462364853,0.509734412112432,MTHFD2,1
WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,1/161,14/3279,0.07142857142857142,1.4547471162377994,0.38741081103970965,0.50652902700559,0.641702462364853,0.509734412112432,PDK1,1
WP_SEROTONIN_AND_ANXIETY,WP_SEROTONIN_AND_ANXIETY,1/161,14/3279,0.07142857142857142,1.4547471162377994,0.38741081103970965,0.50652902700559,0.641702462364853,0.509734412112432,ARC,1
WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,CDK2,1
WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,PLA2G5,1
WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,CDKN1A,1
WP_G13_SIGNALING,WP_G13_SIGNALING,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,CYFIP1,1
WP_GPCRS_CLASS_B_SECRETINLIKE,WP_GPCRS_CLASS_B_SECRETINLIKE,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,ADGRE2,1
WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,BDNF,1
WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,MYC,1
WP_P38_MAPK_SIGNALING,WP_P38_MAPK_SIGNALING,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,MYC,1
WP_TROP2_REGULATORY_SIGNALING,WP_TROP2_REGULATORY_SIGNALING,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,CDK2,1
WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,1/161,15/3279,0.06666666666666667,1.3577639751552795,0.3155342587118697,0.5308625114319605,0.653369244839336,0.5190018855205252,NOS3,1
WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,2/161,36/3279,0.05555555555555555,1.1314699792960663,0.18021200883147212,0.5345224041227467,0.6541463982465342,0.5196192149814087,BDNF/CYFIP1,2
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,2/161,36/3279,0.05555555555555555,1.1314699792960663,0.18021200883147212,0.5345224041227467,0.6541463982465342,0.5196192149814087,MYC/TNIP2,2
WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,2/161,37/3279,0.05405405405405406,1.1008897095853618,0.14022342991000025,0.5495135951198884,0.6685178013785888,0.5310350956369883,CDK2/MYC,2
WP_TCELL_RECEPTOR_SIGNALING,WP_TCELL_RECEPTOR_SIGNALING,2/161,37/3279,0.05405405405405406,1.1008897095853618,0.14022342991000025,0.5495135951198884,0.6685178013785888,0.5310350956369883,IL1B/IL6,2
WP_NOTCH_SIGNALING_WP268,WP_NOTCH_SIGNALING_WP268,1/161,16/3279,0.0625,1.2729037267080745,0.24862241345642166,0.5540031779942935,0.6685178013785888,0.5310350956369883,HES1,1
WP_TAR_SYNDROME,WP_TAR_SYNDROME,1/161,16/3279,0.0625,1.2729037267080745,0.24862241345642166,0.5540031779942935,0.6685178013785888,0.5310350956369883,HAMP,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,1/161,16/3279,0.0625,1.2729037267080745,0.24862241345642166,0.5540031779942935,0.6685178013785888,0.5310350956369883,TLR2,1
WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,2/161,38/3279,0.05263157894736842,1.0719189277541679,0.1013152554654846,0.5641655601983291,0.6788844624113598,0.5392698215060997,OSMR/SOCS3,2
WP_WNT_SIGNALING_WP428,WP_WNT_SIGNALING_WP428,3/161,60/3279,0.05,1.0183229813664598,0.03254547646625676,0.5719850759564531,0.6827905030158072,0.5423725730583654,MYC/VANGL1/FOSL1,3
WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1/161,17/3279,0.058823529411764705,1.1980270369017172,0.1859886014212688,0.5760091505174068,0.6827905030158072,0.5423725730583654,HK2,1
WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1/161,17/3279,0.058823529411764705,1.1980270369017172,0.1859886014212688,0.5760091505174068,0.6827905030158072,0.5423725730583654,VEGFA,1
WP_IL5_SIGNALING,WP_IL5_SIGNALING,1/161,17/3279,0.058823529411764705,1.1980270369017172,0.1859886014212688,0.5760091505174068,0.6827905030158072,0.5423725730583654,MYC,1
WP_OXIDATIVE_STRESS_RESPONSE,WP_OXIDATIVE_STRESS_RESPONSE,1/161,17/3279,0.058823529411764705,1.1980270369017172,0.1859886014212688,0.5760091505174068,0.6827905030158072,0.5423725730583654,MT1X,1
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,2/161,39/3279,0.05128205128205128,1.0444338270425226,0.06342389008559057,0.5784752872772811,0.6827905030158072,0.5423725730583654,DSC2/ITGB3,2
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,2/161,39/3279,0.05128205128205128,1.0444338270425226,0.06342389008559057,0.5784752872772811,0.6827905030158072,0.5423725730583654,MYC/FOSL1,2
WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,2/161,40/3279,0.05,1.0183229813664598,0.026491101632654872,0.5924408696041148,0.6969628070375783,0.5536302999372577,WNT8A/MYC,2
WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,3/161,62/3279,0.04838709677419355,0.9854738529352834,-0.02623615018001528,0.5946039481950947,0.6969628070375783,0.5536302999372577,IL1B/MYC/SMCR5,3
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,1/161,18/3279,0.05555555555555555,1.1314699792960663,0.1270769564978411,0.596935737509037,0.6969628070375783,0.5536302999372577,MYC,1
WP_INTERFERON_TYPE_I_SIGNALING,WP_INTERFERON_TYPE_I_SIGNALING,1/161,18/3279,0.05555555555555555,1.1314699792960663,0.1270769564978411,0.596935737509037,0.6969628070375783,0.5536302999372577,SOCS3,1
WP_HEART_DEVELOPMENT,WP_HEART_DEVELOPMENT,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,VEGFA,1
WP_HISTONE_MODIFICATIONS,WP_HISTONE_MODIFICATIONS,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,H4C2,1
WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,PDK1,1
WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,H4C2,1
WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,IL1B,1
WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,PDK1,1
WP_WNT_SIGNALING_WP363,WP_WNT_SIGNALING_WP363,1/161,19/3279,0.05263157894736842,1.0719189277541679,0.07143163017654813,0.6168355677025497,0.706824841505309,0.5614641772191294,MYC,1
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,3/161,65/3279,0.046153846153846156,0.9399904443382705,-0.11102825402683057,0.6270623067226883,0.7166426362545009,0.5692629128142477,RAC2/FGF2/CD14,3
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,2/161,43/3279,0.046511627906976744,0.9472771919687997,-0.07906929405801666,0.6322682087002438,0.7187891214697508,0.5709679668594999,EGR2/DSC2,2
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,2/161,43/3279,0.046511627906976744,0.9472771919687997,-0.07906929405801666,0.6322682087002438,0.7187891214697508,0.5709679668594999,MYC/FOSL1,2
WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,1/161,20/3279,0.05,1.0183229813664598,0.01867447128133263,0.6357587191135586,0.720860279939783,0.5726131853322839,CDKN1A,1
WP_PRIMARY_OVARIAN_INSUFFICIENCY,WP_PRIMARY_OVARIAN_INSUFFICIENCY,3/161,67/3279,0.04477611940298507,0.9119310280893668,-0.16548244036901202,0.6476970506385842,0.7297706142350886,0.5796910824576971,INHA/IL6/BDNF,3
WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,1/161,21/3279,0.047619047619047616,0.9698314108251996,-0.031511455650843394,0.6537528419189336,0.7297706142350886,0.5796910824576971,BDNF,1
WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,1/161,21/3279,0.047619047619047616,0.9698314108251996,-0.031511455650843394,0.6537528419189336,0.7297706142350886,0.5796910824576971,CD36,1
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1/161,21/3279,0.047619047619047616,0.9698314108251996,-0.031511455650843394,0.6537528419189336,0.7297706142350886,0.5796910824576971,CLDN5,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/161,21/3279,0.047619047619047616,0.9698314108251996,-0.031511455650843394,0.6537528419189336,0.7297706142350886,0.5796910824576971,MYC,1
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,1/161,21/3279,0.047619047619047616,0.9698314108251996,-0.031511455650843394,0.6537528419189336,0.7297706142350886,0.5796910824576971,CDKN1A,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,2/161,45/3279,0.044444444444444446,0.9051759834368531,-0.1455237754768603,0.6571052192827859,0.730412477478946,0.5802009445861024,SOCS3/ITGB3,2
WP_EGFEGFR_SIGNALING,WP_EGFEGFR_SIGNALING,3/161,68/3279,0.04411764705882353,0.8985202776762881,-0.19212900382700432,0.6577093836558101,0.730412477478946,0.5802009445861024,NOS3/LIMK2/PLSCR1,3
WP_MALE_INFERTILITY,WP_MALE_INFERTILITY,2/161,46/3279,0.043478260869565216,0.8854982446664866,-0.17769187305092782,0.6690160381200527,0.7410639191483661,0.5886618850934877,THBS1/NOS3,2
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,3/161,70/3279,0.04285714285714286,0.8728482697426797,-0.24432381047159624,0.6771212694258801,0.7481237554782102,0.5942698447512099,EGR1/RAC2/SOCS3,3
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,2/161,47/3279,0.0425531914893617,0.8666578564820934,-0.209199211070684,0.6805927465564197,0.7500409860009521,0.5957927910241483,WNT8A/HHEX,2
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/161,23/3279,0.043478260869565216,0.8854982446664866,-0.12520256366815957,0.6871331595946263,0.7509410620119652,0.5965077636839685,CDKN1A,1
WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1/161,23/3279,0.043478260869565216,0.8854982446664866,-0.12520256366815957,0.6871331595946263,0.7509410620119652,0.5965077636839685,BDNF,1
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,1/161,23/3279,0.043478260869565216,0.8854982446664866,-0.12520256366815957,0.6871331595946263,0.7509410620119652,0.5965077636839685,CDKN1A,1
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,2/161,48/3279,0.041666666666666664,0.8486024844720497,-0.24007682847446135,0.6918392191684308,0.7509410620119652,0.5965077636839685,LIF/FGF2,2
WP_ERBB_SIGNALING,WP_ERBB_SIGNALING,2/161,48/3279,0.041666666666666664,0.8486024844720497,-0.24007682847446135,0.6918392191684308,0.7509410620119652,0.5965077636839685,CDKN1A/MYC,2
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,2/161,48/3279,0.041666666666666664,0.8486024844720497,-0.24007682847446135,0.6918392191684308,0.7509410620119652,0.5965077636839685,RAC2/ITGB3,2
WP_CARDIAC_PROGENITOR_DIFFERENTIATION,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,1/161,24/3279,0.041666666666666664,0.8486024844720497,-0.1691329523731759,0.702603540830887,0.7575172039352479,0.6017315021512936,FGF2,1
WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1/161,24/3279,0.041666666666666664,0.8486024844720497,-0.1691329523731759,0.702603540830887,0.7575172039352479,0.6017315021512936,BDNF,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,4/161,96/3279,0.041666666666666664,0.8486024844720497,-0.34207032696034106,0.7031583305047093,0.7575172039352479,0.6017315021512936,TNFRSF1A/IL1B/IL6/TUBB6,4
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,3/161,74/3279,0.04054054054054054,0.8256672821890214,-0.34463557139120277,0.7134984637092641,0.7667446177174181,0.6090612704090602,WNT8A/CLDN5/COL4A1,3
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/161,25/3279,0.04,0.8146583850931677,-0.21135548845039617,0.7173134732198969,0.7670282683935532,0.6092865874666139,NOS3,1
WP_NUCLEAR_RECEPTORS,WP_NUCLEAR_RECEPTORS,1/161,25/3279,0.04,0.8146583850931677,-0.21135548845039617,0.7173134732198969,0.7670282683935532,0.6092865874666139,NR4A1,1
WP_10Q22Q23_COPY_NUMBER_VARIATION,WP_10Q22Q23_COPY_NUMBER_VARIATION,1/161,26/3279,0.038461538461538464,0.7833253702818921,-0.2520182912494825,0.7313001145264723,0.7800534554949037,0.6196331054857179,VEGFA,1
WP_OXIDATION_BY_CYTOCHROME_P450,WP_OXIDATION_BY_CYTOCHROME_P450,1/161,27/3279,0.037037037037037035,0.7543133195307108,-0.2912511060639193,0.7445988177423464,0.790335845859198,0.6278008912039439,CYP2G1P,1
WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1/161,27/3279,0.037037037037037035,0.7543133195307108,-0.2912511060639193,0.7445988177423464,0.790335845859198,0.6278008912039439,MTHFD2,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,4/161,103/3279,0.038834951456310676,0.7909304709642404,-0.48983347760335993,0.754470913092024,0.7988515550386136,0.6345653190608871,TNFRSF1A/IL1B/IL6/TUBB6,4
WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,1/161,29/3279,0.034482758620689655,0.7022917112872136,-0.3658706753064054,0.7692653166073341,0.8125247353896536,0.6454265685600076,GDNF,1
WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,1/161,30/3279,0.03333333333333333,0.6788819875776397,-0.40144845972487403,0.7806955578461707,0.820585111896705,0.6518293042844197,VEGFA,1
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1/161,30/3279,0.03333333333333333,0.6788819875776397,-0.40144845972487403,0.7806955578461707,0.820585111896705,0.6518293042844197,EDN1,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,3/161,84/3279,0.03571428571428571,0.7273735581188997,-0.5751108280961764,0.7906165144455901,0.8259786848541412,0.65611367266678855,EGR1/IL6/HCRTR2,3
WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,1/161,31/3279,0.03225806451612903,0.6569825686235223,-0.4359818243246295,0.791562906318552,0.8259786848541412,0.65611367266678855,CDKN1A,1
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,1/161,31/3279,0.03225806451612903,0.6569825686235223,-0.4359818243246295,0.791562906318552,0.8259786848541412,0.65611367266678855,SLC22A6,1
WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,1/161,32/3279,0.03125,0.6364518633540373,-0.4695427347443264,0.8018949174277616,0.8347436248886578,0.6630760763004447,GDNF,1
WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,1/161,34/3279,0.029411764705882353,0.5990135184508586,-0.5339999257765861,0.8210565097519938,0.8526356062809167,0.6772885176597925,H4C2,1
WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,2/161,63/3279,0.031746031746031744,0.6465542738834664,-0.643597496982186,0.8244745302006838,0.8541318874021473,0.6784770840475147,WNT8A/FGF2,2
WP_AXON_GUIDANCE,WP_AXON_GUIDANCE,1/161,36/3279,0.027777777777777776,0.5657349896480331,-0.5952672260220675,0.8383751066460668,0.8664546556724902,0.6882656377905259,EFNA1,1
WP_CILIOPATHIES,WP_CILIOPATHIES,2/161,67/3279,0.029850746268656716,0.6079540187262445,-0.7366581477058443,0.8499587717161294,0.8763298075927636,0.6961099348811913,PLK4/CCNO,2
WP_CHOLESTEROL_METABOLISM,WP_CHOLESTEROL_METABOLISM,1/161,39/3279,0.02564102564102564,0.5222169135212613,-0.6819773127482862,0.8612783293956646,0.8837820387147913,0.7020295921564862,CD36,1
WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,1/161,39/3279,0.02564102564102564,0.5222169135212613,-0.6819773127482862,0.8612783293956646,0.8837820387147913,0.7020295921564862,IL6,1
WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,2/161,74/3279,0.02702702702702703,0.5504448547926809,-0.8887184017194424,0.886623681442392,0.9036078674621147,0.7177781793193211,CHST3/GAL3ST4,2
WP_THERMOGENESIS,WP_THERMOGENESIS,1/161,43/3279,0.023255813953488372,0.47363859598439984,-0.7893931713627754,0.8868743884350385,0.9036078674621147,0.7177781793193211,ACSL5,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/161,43/3279,0.023255813953488372,0.47363859598439984,-0.7893931713627754,0.8868743884350385,0.9036078674621147,0.7177781793193211,ITGB3,1
WP_RAS_SIGNALING,WP_RAS_SIGNALING,2/161,76/3279,0.02631578947368421,0.5359594638770839,-0.929958576184418,0.8954735686309192,0.9102225450554283,0.723032528479702,PLA2G5/RAC2,2
WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,1/161,45/3279,0.022222222222222223,0.45258799171842656,-0.8400979527528796,0.8978526450310383,0.9104984569328839,0.723251698245907,BDNF,1
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,2/161,82/3279,0.024390243902439025,0.49674291773973644,-1.0485879451179407,0.9183317044901436,0.9290850031375691,0.738015865065418,RGS16/GJB3,2
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/161,59/3279,0.01694915254237288,0.3451942309716812,-1.153160941869504,0.950099985995609,0.9589794251170631,0.7617624088405522,TRIP10,1
WP_ADHD_AND_AUTISM_ASD_PATHWAYS,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,4/161,162/3279,0.024691358024691357,0.5028755463538073,-1.4744620193047175,0.9632738115034748,0.9700099920034992,0.7705245063185691,MTHFD2/NOS3/OXTR/PNP,4
WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,4/161,165/3279,0.024242424242424242,0.4937323546019198,-1.5161500987173886,0.9670318872414178,0.9715297099727733,0.7717316896957215,TRIP10/CLEC4F/ACSL5/ARC,4
WP_CHEMOKINE_SIGNALING,WP_CHEMOKINE_SIGNALING,1/161,73/3279,0.0136986301369863,0.27899259763464646,-1.4154637506536454,0.975701285026025,0.9779650931119322,0.7768436168481724,RAC2,1
WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,1/161,78/3279,0.01282051282051282,0.26110845676063066,-1.5005985327811977,0.9812228139894426,0.9812228139894426,0.7794313775842064,HES1,1
